Fig. 2From: The pro-inflammatory marker soluble suppression of tumorigenicity-2 (ST2) is reduced especially in diabetic morbidly obese patients undergoing bariatric surgeryLevels of sST2 are higher in obese individuals with diabetes. Box-whisker plot showing basal serum sST2 concentrations (pg/mL) stratified according to the presence of diabetes. sST2 was determined in samples obtained before bariatric surgery as indicated in MethodsBack to article page